These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 28930537)

  • 1. Differences in ion channel phenotype and function between humans and animal models.
    Tanner MR; Beeton C
    Front Biosci (Landmark Ed); 2018 Jan; 23(1):43-64. PubMed ID: 28930537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis.
    Bishop MD; Freedman SD; Zielenski J; Ahmed N; Dupuis A; Martin S; Ellis L; Shea J; Hopper I; Corey M; Kortan P; Haber G; Ross C; Tzountzouris J; Steele L; Ray PN; Tsui LC; Durie PR
    Hum Genet; 2005 Dec; 118(3-4):372-81. PubMed ID: 16193325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biogenesis, traffic, and function of the cystic fibrosis transmembrane conductance regulator.
    Jilling T; Kirk KL
    Int Rev Cytol; 1997; 172():193-241. PubMed ID: 9102394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Swelling-activated Ca2+ entry via TRPV4 channel is defective in cystic fibrosis airway epithelia.
    Arniges M; Vázquez E; Fernández-Fernández JM; Valverde MA
    J Biol Chem; 2004 Dec; 279(52):54062-8. PubMed ID: 15489228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel, mechanism-based therapies for cystic fibrosis.
    Rubenstein RC
    Curr Opin Pediatr; 2005 Jun; 17(3):385-92. PubMed ID: 15891431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in CFTR associated with mild-disease-form Cl- channels with altered pore properties.
    Sheppard DN; Rich DP; Ostedgaard LS; Gregory RJ; Smith AE; Welsh MJ
    Nature; 1993 Mar; 362(6416):160-4. PubMed ID: 7680769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ion Channel Modulators in Cystic Fibrosis.
    Gentzsch M; Mall MA
    Chest; 2018 Aug; 154(2):383-393. PubMed ID: 29750923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic fibrosis. Sickly channels in mild disease.
    Miller C
    Nature; 1993 Mar; 362(6416):106. PubMed ID: 7680767
    [No Abstract]   [Full Text] [Related]  

  • 9. [Modifier genes and cystic fibrosis].
    Corvol H; Flamant C; Vallet C; Clement A; Brouard J
    Arch Pediatr; 2006 Jan; 13(1):57-63. PubMed ID: 16274977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.
    Dalemans W; Barbry P; Champigny G; Jallat S; Dott K; Dreyer D; Crystal RG; Pavirani A; Lecocq JP; Lazdunski M
    Nature; 1991 Dec 19-26; 354(6354):526-8. PubMed ID: 1722027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cystic fibrosis transmembrane conductance regulator: an intriguing protein with pleiotropic functions.
    Vankeerberghen A; Cuppens H; Cassiman JJ
    J Cyst Fibros; 2002 Mar; 1(1):13-29. PubMed ID: 15463806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-associated mutations in cytoplasmic loops 1 and 2 of cystic fibrosis transmembrane conductance regulator impede processing or opening of the channel.
    Seibert FS; Jia Y; Mathews CJ; Hanrahan JW; Riordan JR; Loo TW; Clarke DM
    Biochemistry; 1997 Sep; 36(39):11966-74. PubMed ID: 9305991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cystic fibrosis and congenital bilateral absence of the vas deferens-associated mutations on cystic fibrosis transmembrane conductance regulator-mediated regulation of separate channels.
    Mickle JE; Milewski MI; Macek M; Cutting GR
    Am J Hum Genet; 2000 May; 66(5):1485-95. PubMed ID: 10762539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway inflammation and ion channel abnormalities in cystic fibrosis.
    Shute J
    Clin Exp Allergy; 2000 Dec; 30(12):1676-81. PubMed ID: 11122204
    [No Abstract]   [Full Text] [Related]  

  • 15. [The impact of hypoxia on the ion channels in cystic fibrosis bronchial epithelial cells].
    Pascarel K; Colas J; Mirval S; Becq F; Vandebrouck C
    Rev Mal Respir; 2023 Mar; 40(3):230-233. PubMed ID: 36775781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What we know and what we do not know about cystic fibrosis transmembrane conductance regulator.
    Ma J; Davis PB
    Clin Chest Med; 1998 Sep; 19(3):459-71, v-vi. PubMed ID: 9759549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primers on molecular pathways - ion channels: key regulators of pancreatic physiology.
    Banales JM; Gradilone SA
    Pancreatology; 2009; 9(5):556-9. PubMed ID: 19590254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional disruption of the ClC-2 Cl(-) channel does not exacerbate the cystic fibrosis phenotype of cystic fibrosis transmembrane conductance regulator mouse models.
    Zdebik AA; Cuffe JE; Bertog M; Korbmacher C; Jentsch TJ
    J Biol Chem; 2004 May; 279(21):22276-83. PubMed ID: 15007059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the discovery and development of CFTR chloride channel activators.
    Becq F
    Curr Pharm Des; 2006; 12(4):471-84. PubMed ID: 16472140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic fibrosis. Channelling our thoughts.
    Higgins CF; Hyde SC
    Nature; 1991 Jul; 352(6332):194-5. PubMed ID: 1713302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.